These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14092546)

  • 1. [ANTIPLASMIN DRUGS].
    MATSUOKA S; OGUCHI G
    Sogo Rinsho; 1963 Oct; 12():1986-91. PubMed ID: 14092546
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 3. [ANTIFIBRINOLYTIC AGENTS].
    ZWEIBAUM A; JOSSO F
    Rev Prat; 1963 Dec; 13():SUPPL 135-8. PubMed ID: 14099272
    [No Abstract]   [Full Text] [Related]  

  • 4. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 5. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.
    SWEENEY WM
    Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS].
    PERLICK E
    Dtsch Gesundheitsw; 1964 May; 19():900-3. PubMed ID: 14220146
    [No Abstract]   [Full Text] [Related]  

  • 7. AORTIC ARTERIOSCLEROSIS IN RABBITS. FED INHIBITORS OF FIBRINOLYSIS.
    KWAAN HC; ASTRUP T
    Arch Pathol; 1964 Nov; 78():474-82. PubMed ID: 14200668
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE PHARMACOLOGIC PROPERTIES OF A NEW ANTIFIBRINOLYTIC, PARA-AMINOMETHYLBENZOIC ACID].
    MARKWARDT F; HAUSTEIN KO; KLOECKING HP
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():223-33. PubMed ID: 14248348
    [No Abstract]   [Full Text] [Related]  

  • 9. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACIDS].
    SAMAMA M; MARCHAL G; BILSKI-PASQUIER G; DUHAMEL G; CASUBOLO
    Sangre (Barc); 1964; 41():367-70. PubMed ID: 14248818
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
    MARKWARDT F; KLOECKING HP; RICHTER M
    Acta Biol Med Ger; 1964; 12():522-4. PubMed ID: 14134957
    [No Abstract]   [Full Text] [Related]  

  • 11. [AN EFFECTIVE ANTIFIBRINOLYTIC AGENT: EPSILON-AMINOCAPROIC ACID].
    GROSSI F
    Clin Ter; 1963 Jul; 26():73-8. PubMed ID: 14050038
    [No Abstract]   [Full Text] [Related]  

  • 12. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 13. 2 CASES OF FIBRINOLYSIS DURING SHUNT OPERATION IN CIRRHOSIS OF THE LIVER.
    LEIBA H; RAMOT B; MANY A
    Isr Med J; 1964; 23():176-80. PubMed ID: 14215370
    [No Abstract]   [Full Text] [Related]  

  • 14. ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS.
    MAXWELL RE; LEWANDOWSKI V; NICKEL VS
    Life Sci (1962); 1965 Jan; 4():45-51. PubMed ID: 14257064
    [No Abstract]   [Full Text] [Related]  

  • 15. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
    PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J
    Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868
    [No Abstract]   [Full Text] [Related]  

  • 16. [INDICATIONS AND HANDLING OF FIBRINOLYTIC ENZYME INHIBITORS].
    BERNARD J; BOUSSER J; DREYFUS B; HAMBURGER J; PEQUIGNOT H
    Presse Med (1893); 1964 Jan; 72():167-9. PubMed ID: 14106785
    [No Abstract]   [Full Text] [Related]  

  • 17. [EFFECT OF EPSILON-AMINOCAPROIC ACID ON EXPERIMENTAL PANCREATITIS IN RATS].
    DIWOK K; GUELZOW M; TRETTIN HJ
    Z Gesamte Inn Med; 1965 Feb; 20():111-2. PubMed ID: 14264674
    [No Abstract]   [Full Text] [Related]  

  • 18. STUDIES ON THE FIBRINOLYSIS IN TUMOR BEARING MICE. I. FIBRINOLYTIC SYSTEM, ASCITES RETENTION AND INTRAPERITONEAL HEMORRHAGE IN TUMOR BEARING MICE: SUPPRESSING EFFECT OF EPSILON AMINOCAPROIC ACID.
    KINJO K; HIRATA T; OKAMOTO S
    Kobe J Med Sci; 1963 Dec; 18():151-60. PubMed ID: 14160535
    [No Abstract]   [Full Text] [Related]  

  • 19. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICAL EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID AS AN ANTIFIBRINOLYTIC AGENT IN VARIOUS OBSTETRICAL DISORDERS].
    PALACIO S; CANO A; YEPES E
    Rev Colomb Obstet Ginecol; 1964; 15():413-9. PubMed ID: 14258173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.